Skip to main content

Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities (npj Precision Oncology, (2024), 8, 1, (68), 10.1038/s41698-024-00519-8)

Publication ,  Journal Article
Bateman, NW; Abulez, T; Soltis, AR; McPherson, A; Choi, S; Garsed, DW; Pandey, A; Tian, C; Hood, BL; Conrads, KA; Teng, PN; Oliver, J; Yan, C ...
Published in: Npj Precision Oncology
December 1, 2024

Correction to: npj Precision Oncologyhttps://doi.org/10.1038/s41698-024-00519-8, published online 13 March 2024 In the original version of this article, the wrong file was inadvertently supplied for Supplementary Data 15. The original article has been corrected.

Duke Scholars

Published In

Npj Precision Oncology

DOI

EISSN

2397-768X

Publication Date

December 1, 2024

Volume

8

Issue

1

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bateman, N. W., Abulez, T., Soltis, A. R., McPherson, A., Choi, S., Garsed, D. W., … Maxwell, G. L. (2024). Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities (npj Precision Oncology, (2024), 8, 1, (68), 10.1038/s41698-024-00519-8). Npj Precision Oncology, 8(1). https://doi.org/10.1038/s41698-024-00588-9
Bateman, N. W., T. Abulez, A. R. Soltis, A. McPherson, S. Choi, D. W. Garsed, A. Pandey, et al. “Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities (npj Precision Oncology, (2024), 8, 1, (68), 10.1038/s41698-024-00519-8).” Npj Precision Oncology 8, no. 1 (December 1, 2024). https://doi.org/10.1038/s41698-024-00588-9.
Bateman NW, Abulez T, Soltis AR, McPherson A, Choi S, Garsed DW, Pandey A, Tian C, Hood BL, Conrads KA, Teng PN, Oliver J, Gist G, Mitchell D, Litzi TJ, Tarney CM, Crothers BA, Mhawech-Fauceglia P, Dalgard CL, Wilkerson MD, Pierobon M, Petricoin EF, Yan C, Meerzaman D, Bodelon C, Wentzensen N, Lee JSH, Makohon-Moore SC, Barakat W, Zhang X, Hunt A, Ao W, Lytle-Gabbin SL, Casablanca Y, Hamilton CA, Newell M, Wells J, Sukumar G, Bacikova D, Freyman J, Cohn DE, Berchuck A, Havrilesky L, Duska L, Odunsi A, Sood A, Brenton J, Sala E, Annunziata C, Dorigo O, Nelson B, Cochrane DR, Moore K, Baldelli E, Chen QR, Hu Y, Fereday S, Traficante N, DeFazio A, Goode EL, Huntsman DG, Shah S, Shriver CD, Phippen NT, Darcy KM, Bowtell DDL, Conrads TP, Maxwell GL. Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities (npj Precision Oncology, (2024), 8, 1, (68), 10.1038/s41698-024-00519-8). Npj Precision Oncology. 2024 Dec 1;8(1).

Published In

Npj Precision Oncology

DOI

EISSN

2397-768X

Publication Date

December 1, 2024

Volume

8

Issue

1

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology